Access Bio: Access Bio Granted Emergency Use Authorization by FDA

Somerset-based Access Bio, Inc., a leader in the development of diagnostic tests for infectious diseases through research, development and manufacturing, announced that the U.S. Food and Drug Administration (FDA) has granted the company Emergency Use Authorization (EUA) for its SARS CoV-2 RT-PCR test. Manufactured entirely in the United States, the CareStart COVID-19 MDx RT-PCR test [...] The post Access Bio Granted Emergency Use Authorization by FDA appeared first on New Jersey Business Magazine.